Peak

Peak carries two related but distinct meanings in substance pharmacology. The first is the plasma peak (commonly written as Cmax) — the highest concentration a drug reaches in the bloodstream after a dose. The second is the subjective peak: the most intense stretch of perceived effects, which users and researchers alike often simply call the peak.

These two moments rarely coincide. The plasma peak reflects how much of a substance is circulating in the blood; the subjective peak reflects how fully it is acting at its targets — typically receptors in the brain. Depending on the compound, the gap between them can stretch from minutes to hours.

Neither marks the end of a drug's reach. Concentrations, cognitive impairment, and physiological effects can persist well past both peaks, which is why the peak alone is not a reliable guide to when a substance has cleared.

How it works · its role

After a substance is absorbed, plasma concentration climb until the rate of elimination overtakes the rate of absorption — that crossover defines Cmax. The time at which it occurs is called Tmax, and it depends heavily on route of administration: inhalation reaches Cmax in minutes, while oral ingestion typically takes one to three hours, longer for extended-release formulations.

The subjective peak follows different logic. A substance must cross the blood-brain barrier, distribute into brain tissue, and bind a sufficient proportion of its target receptors before effects reach their height. Some compounds are converted to active metabolites that do the real pharmacological work — meaning the subjective peak may arrive well after the parent compound has peaked in blood.

Effects do not mirror the concentration curve symmetrically. With many substances the brain adapts during a single session, so the same blood level produces noticeably weaker effects on the descending limb than it did on the ascent. Pharmacokineticists call this pattern hysteresis; it means the peak of felt effects and the peak of blood concentration can be separated even when both appear to fall within the same window.

Relevance to substances & effects

The relationship between plasma peak and subjective peak shapes how a dose is experienced — and where errors happen. With inhaled cannabis, Cmax arrives within minutes and the subjective peak typically follows closely. With oral cannabis, blood concentrations may continue rising for an hour or more after ingestion, and many redosing mistakes occur because the subjective peak has not yet arrived when someone assumes the first dose has failed.

Serotonergic psychedelics such as LSD and psilocybin-containing mushrooms produce subjective peaks that last several hours. The concentration of the active compound may already be declining while effects remain intense, partly because of slow receptor dissociation and partly because active metabolites continue to accumulate. Opioids present a different profile: the analgesic peak and the respiratory-depressant peak may not align, which has direct implications for overdose risk.

Stimulants and empathogens often produce a sharper, more clearly defined peak that users describe as the clearest marker of onset and offset. The steepness of the ascent matters: substances that rise quickly to their peak tend to produce stronger reinforcement than those reaching the same concentration over a longer curve — a pattern that appears consistently across substance classes.